Human Hepatitis B Immunoglobulin for Intravenous Injection(PH4)

Therapeutic indications 1) Prevention of hepatitis B after liver transplantation in patients who carry the surface antigen of          the hepatitis B  virus.            2) Groups infected accidentally: blood transfusion, haemophile, renal dialysis patient, medical                        care personnel  or personnel with injured skin, personnel contacting patients contaminated by                    blood and secretion of  positive surface antigen of the hepatitis B virus, etc

Lyophilized Powder For Injection Topical Medication Small Volume Parenterals Plasma Product